Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My forecast

I do not think that the 20 dollar per share figures are rational.

Assuming a 200 million dollar settlement and approximately 150 million per Q thereafter the forcecasted succeeding 12 month settlemnt/license dollars will be approximately 800 million of which PTSC will receive

about 98% of 50% and then pay 35% taxes onthat amount.

That leaves about 250 million for PTSC less expenses ( assume 10% ) or 225 million or about 57 cents per share net

Using a reaonable PE of 10 - 11 given the short remaining life span of the patents

My 12 month projection ASSUMING THAT WE HAVE INDEED SETTLED

Will be about 6 - 7 dollars per share.

Not bad But not 20 or 50 as someare suggesting.

Remember, the most important thing is whether JT knows how to invest the

winnnings will he invest well or blow his wad as do most lottery winners.

Share
New Message
Please login to post a reply